tradingkey.logo
tradingkey.logo

Merck Nears $6Bn Biotech Deal To Boost Cancer Drug Pipeline - Ft

ReutersMar 25, 2026 1:03 AM

- FINANCIAL TIMES:

  • MERCK NEARS $6BN BIOTECH DEAL TO BOOST CANCER DRUG PIPELINE - FT

  • MERCK'S ALL-CASH DEAL IS EXPECTED TO VALUE TERNS AT ROUGHLY $6BN - FT

  • TALKS BETWEEN MERCK AND TERNS WERE AT AN ADVANCED STAGE AND DEAL COULD BE REACHED IN COMING DAYS - FT

Source text: https://tinyurl.com/23btjdhn

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI